Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance

Genome Research

Volumn 19, Issue 7, 2009, Pages 1214-1223

  Feng, Jie ^a,b   Lupien, Andréanne ^a,b   Gingras, Hélène ^a,b   Wasserscheid, Jessica ^c   Dewar, Ken ^c   Légaré, Danielle ^a,b   Ouellette, Marc ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHLORAMPHENICOL; ERYTHROMYCIN; FLORFENICOL; LINEZOLID; RIBOSOME RNA; RNA 23S; RNA METHYLTRANSFERASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG MECHANISM; GENE DELETION; GENE INACTIVATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NONSENSE MUTATION; OPERON; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; MUTATION; OXAZOLIDINONES; PHYLOGENY; RNA, RIBOSOMAL, 23S; SEQUENCE HOMOLOGY, NUCLEIC ACID; STREPTOCOCCUS PNEUMONIAE; TRNA METHYLTRANSFERASES;

STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 67650087598     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.089342.108     Document Type: Article

References (67)

1. Albert TJ, Dailidiene D, Dailide G, Norton JE, Kalia A, Richmond TA, Molla M, Singh J, Green RD, Berg DE. 2005. Mutation discovery in bacterial genomes: Metronidazole resistance in Helicobacter pylori. Nat Methods 2: 951-953.
2. Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, et al. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223-227.
3. Besier S, Ludwig A, Zander J, Brade V, Wichelhaus TA. 2008. Linezolid resistance in Staphylococcus aureus: Gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 52: 1570-1572.
4. Blaha G, Gurel G, Schroeder SJ, Moore PB, Steitz TA. 2008. Mutations outside the anisomycin-binding site can make ribosomes drug-resistant. J Mol Biol 379: 505-519.
5. Bourgeois-Nicolaos N, Massias L, Couson B, Butel MJ, Andremont A, Doucet-Populaire F. 2007. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 195: 1480-1488.
6. Buckley ND, Lee LN, LeBlanc DJ. 1995. Use of a novel mobilizable vector to inactivate the scrA gene of Streptococcus sobrinus by allelic replacement. J Bacteriol 177: 5028-5034.
7. Carsenti-Dellamonica H, Galimand M, Vandenbos F, Pradier C, Roger PM, Dunais B, Sabah M, Mancini G, Dellamonica P. 2005. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: Relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother 56: 633-642.
8. Drummelsmith J, Winstall E, Bergeron MG, Poirier GG, Ouellette M. 2007. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains. J Proteome Res 6: 4690-4702.
9. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, et al. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2: e7. doi: 10.1371/journal.pgen.0020007.
10. Fournier PE, Drancourt M, Raoult D. 2007. Bacterial genome sequencing and its use in infectious diseases. Lancet Infect Dis 7: 711-723.
11. Fouts DE, Mongodin EF, Mandrell RE, Miller WG, Rasko DA, Ravel J, Brinkac LM, DeBoy RT, Parker CT, Daugherty SC, et al. 2005. Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol 3: e15. doi: 10.1371/journal.pbio.0030015.
12. Francois P, Hernandez D, Schrenzel J. 2007. Genome content determination in methicillin-resistant Staphylococcus aureus. Future Microbiol 2: 187-198.
13. Gill MJ, Brenwald NP, Wise R. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 43: 187-189.
14. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, et al. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426-2438.
15. Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357: 1179.
16. Gregory ST, Carr JF, Rodriguez-Correa D, Dahlberg AE. 2005. Mutational analysis of 16S and 23S rRNA genes of Thermus thermophilus. J Bacteriol 187: 4804-4812.
17. Hernandez D, Francois P, Farinelli L, Osteras M, Schrenzel J. 2008. De novo bacterial genome sequencing: Millions of very short reads assembled on a desktop computer. Genome Res 18: 802-809.
18. Highlander SK, Hulten KG, Qin X, Jiang H, Yerrapragada S, Mason EO Jr, Shang Y, Williams TM, Fortunov RM, Liu Y, et al. 2007. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol 7: 99. doi: 10.1186/1471-2180-7-99.
19. Hiller NL, Janto B, Hogg JS, Boissy R, Yu S, Powell E, Keefe R, Ehrlich NE, Shen K, Hayes J, et al. 2007. Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: Insights into the pneumococcal supragenome. J Bacteriol 189: 8186-8195.
20. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, Rance R, Baker S, Maskell DJ, Wain J, et al. 2008. High-throughput sequencing provides insights into genome variation and evolution in Salmonella typhi. Nat Genet 40: 987-993.
21. Hong T, Li X, Wang J, Sloan C, Cicogna C. 2007. Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation. J Clin Microbiol 45: 3277-3280.
22. Hoskins J, Alborn WE Jr, Arnold J, Blaszczak LC, Burgett S, DeHoff BS, Estrem ST, Fritz L, Fu DJ, Fuller W, et al. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 183: 5709-5717.
23. Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, Davies JK. 2008. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 52: 3755-3762.
24. Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, Duffy EM. 2008. Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J Med Chem 51: 3353-3356.
25. Jones RN, Fritsche TR, Sader HS, Ross JE. 2007. Zyvox annual appraisal of potency and spectrum program results for 2006: An activity and spectrum analysis of linezolid using clinical isolates from 16 countries. Diagn Microbiol Infect Dis 59: 199-209.
26. Joyce EA, Chan K, Salama NR, Falkow S. 2002. Redefining bacterial populations: A post-genomic reformation. Nat Rev Genet 3: 462-473.
27. Kahvejian A, Quackenbush J, Thompson JF. 2008. What would you do if you could sequence everything? Nat Biotechnol 26: 1125-1133.
28. Kelly S, Collins J, Maguire M, Gowing C, Flanagan M, Donnelly M, Murphy PG. 2008. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother 61: 901-907.
29. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla JR, Byrne KA, Parkins LD, Tenover FC, et al. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc Natl Acad Sci 105: 1327-1332.
30. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225-1240.
31. Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, Gadwood RC, Shinabarger D, Xiong L, Mankin AS. 2007. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 26: 393-402.
32. Lesnyak DV, Sergiev PV, Bogdanov AA, Dontsova OA. 2006. Identification of Escherichia coli m2G methyltransferases: I. The ycbY gene encodes a methyltransferase specific for G2445 of the 23 S rRNA. J Mol Biol 364: 20-25.
33. Lubelski J, Konings WN, Driessen AJ. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol Mol Biol Rev 71: 463-476.
34. Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, Norton JE, Daniels L, Dick T, Pang SS, Barry CE III. 2006. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci 103: 431-436.
35. Marrer E, Satoh AT, Johnson MM, Piddock LJ, Page MG. 2006a. Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin. Antimicrob Agents Chemother 50: 269-278.
36. Marrer E, Schad K, Satoh AT, Page MG, Johnson MM, Piddock LJ. 2006b. Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother 50: 685-693.
37. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB. 2002. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 46: 3334-3336.
38. Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 44: 231-238.
39. Meka VG, Gold HS. 2004. Antimicrobial resistance to linezolid. Clin Infect Dis 39: 1010-1015.
40. Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC Jr, Gold HS. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 190: 311-317.
41. Mendes RE, Deshpande LM, Castanheira M, Dipersio J, Saubolle M, Jones RN. 2008. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 52: 2244-2246.
42. Munoz R, Dowson CG, Daniels M, Coffey TJ, Martin C, Hakenbeck R, Spratt BG. 1992. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol 6: 2461-2465.
43. Mutnick AH, Enne V, Jones RN. 2003. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Ann Pharmacother 37: 769-774.
44. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, et al. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci 104: 9451-9456.
45. Ouellette M, Légaré D. 2002. Clinical relevance of drug resistance mediated by ABC-transporters in parasites of humans. In ABC transporters (eds. B. Holland et al.), pp. 317-333. Academic Press, New York.
46. Ouellette M, Legare D, Papadopoulou B. 1994. Microbial multidrug-resistance ABC transporters. Trends Microbiol 2: 407-411.
47. Pringle M, Poehlsgaard J, Vester B, Long KS. 2004. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol Microbiol 54: 1295-1306.
48. Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J, Peterson LR, Noskin GA. 2001. Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45: 2154-2156.
49. Richter E, Rusch-Gerdes S, Hillemann D. 2007. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 51: 1534-1536.
50. Roberts MC. 2008. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 282: 147-159.
51. Robertson GT, Doyle TB, Lynch AS. 2005. Use of an efflux-deficient streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob Agents Chemother 49: 4781-4783.
52. Ruggero KA, Schroeder LK, Schreckenberger PC, Mankin AS, Quinn JP. 2003. Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: Evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis 47: 511-513.
53. Sander P, Belova L, Kidan YG, Pfister P, Mankin AS, Bottger EC. 2002. Ribosomal and non-ribosomal resistance to oxazolidinones: Species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol 46: 1295-1304.
54. Schlunzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814-821.
55. Sinclair A, Arnold C, Woodford N. 2003. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci. Antimicrob Agents Chemother 47: 3620-3622.
56. Soualhine H, Brochu V, Menard F, Papadopoulou B, Weiss K, Bergeron MG, Legare D, Drummelsmith J, Ouellette M. 2005. A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol Microbiol 58: 1430-1440.
57. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, et al. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506.
58. Thornsberry C, Brown NP, Draghi DC, Evangelista AT, Yee YC, Sahm DF. 2008. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005. Postgrad Med 120: 32-38.
59. Toh SM, Mankin AS. 2008. An indigenous posttranscriptional modification in the ribosomal peptidyl transferase center confers resistance to an array of protein synthesis inhibitors. J Mol Biol 380: 593-597.
60. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, Mankin AS. 2007. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 64: 1506-1514.
61. Tsakris A, Pillai SK, Gold HS, Thauvin-Eliopoulos C, Venkataraman L, Wennersten C, Moellering RC Jr, Eliopoulos GM. 2007. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus. J Antimicrob Chemother 60: 649-651.
62. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358: 207-208.
63. Vara Prasad JV. 2007. New oxazolidinones. Curr Opin Microbiol 10: 454-460.
64. Wilson DN, Schluenzen F, Harms JM, Starosta AL, Connell SR, Fucini P. 2008. The oxazolidinone antibiotics perturb the ribosomal peptidyltransferase center and effect tRNA positioning. Proc Natl Acad Sci 105: 13339-13344.
65. Wilson P, Andrews JA, Charlesworth R, Walesby R, Singer M, Farrell DJ, Robbins M. 2003. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 51: 186-188.
66. Wolter N, Smith AM, Farrell DJ, Schaffner W, Moore M, Whitney CG, Jorgensen JH, Klugman KP. 2005. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother 49: 3554-3557.
67. Xiong L, Kloss P, Douthwaite S, Andersen NM, Swaney S, Shinabarger DL, Mankin AS. 2000. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J Bacteriol 182: 5325-5331.